Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-1998 | 12-1997 | 06-1994 | 03-1994 | 12-1993 | |
| Sales | 20 | 10 | 513 | 444 | 0 |
| Cost of Goods | 10 | 5 | 410 | 356 | N/A |
| Gross Profit | 10 | 6 | 103 | 88 | N/A |
| Operating Expenses | 35 | 19 | 902 | 1,254 | 0 |
| Operating Income | -15 | -9 | -389 | -810 | N/A |
| Interest Expense | 10 | 10 | 39 | 4 | 0 |
| Other Income | 23 | 9 | -15 | -21 | 0 |
| Pre-tax Income | -2 | -10 | -442 | -835 | 0 |
| Net Income Continuous | -2 | -10 | -442 | -835 | N/A |
| Net Income | $-2 | $-10 | $-442 | $-835 | $N/A |
| EPS Basic Total Ops | N/A | N/A | -116.39 | -278.17 | N/A |
| EPS Basic Continuous Ops | N/A | N/A | -116.39 | -278.17 | N/A |
| EPS Diluted Total Ops | N/A | N/A | -116.39 | -278.17 | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | -116.39 | -278.17 | N/A |
| EBITDA(a) | $-11 | $-4 | $-389 | $-810 | $193 |